Лікування стафілококових інфекцій у дорослих антибіотиками
Infection | Antibiotics |
|---|---|
Community-acquired cutaneous infections (non-MRSA) | Dicloxacillin or cephalexin |
Penicillin-allergic patients | Erythromycin Clarithromycin Azithromycin Clindamycin |
Community-acquired cutaneous infections likely to be due to MRSA | Sulfamethoxazole/trimethoprim Clindamycin Linezolid Tedizolid Delafloxacin Omadacycline |
Sulfa-allergic patients | Clindamycin Linezolid Tedizolid Doxycycline Delafloxacin Omadacycline |
Serious infections unlikely to be due to MRSA | Nafcillin or oxacillin Cefazolin |
Penicillin-allergic patients | Clindamycin Vancomycin |
Serious infection highly likely to be due to MRSA | Vancomycin Linezolid Daptomycin Ceftobiprole (not available in the United States) Ceftaroline Delafloxacin Omadacycline 2 |
Documented MRSA | By reported sensitivities |
Vancomycin-resistant staphylococci* | Linezolid Quinupristin/dalfopristin Daptomycin Oritavancin Ceftobiprole (not available in the United States) Ceftaroline |
* No clinical data are available, but listed antibiotics appear to be active in vitro. | |
MRSA = methicillin-resistant Staphylococcus aureus. | |